Sequana Medical NV (SEQUA.BR)
EUR 0.72
(3.43%)
EUR 0.72
(3.43%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 30.03 Million EUR | 4.26% |
| 2022 | 28.81 Million EUR | 25.78% |
| 2021 | 22.9 Million EUR | 23.61% |
| 2020 | 18.53 Million EUR | 25.76% |
| 2019 | 14.73 Million EUR | 5.65% |
| 2018 | 13.94 Million EUR | 63.9% |
| 2017 | 8.5 Million EUR | -43.69% |
| 2016 | 15.11 Million EUR | 19.18% |
| 2015 | 12.68 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 4.9 Million EUR | 0.0% |
| 2024 Q1 | 4.9 Million EUR | -30.47% |
| 2023 Q1 | 7.78 Million EUR | -38.58% |
| 2023 Q3 | 7.54 Million EUR | -43.34% |
| 2023 Q4 | 7.05 Million EUR | -6.45% |
| 2023 Q2 | 13.31 Million EUR | 71.11% |
| 2023 FY | 25.59 Million EUR | -11.15% |
| 2022 Q2 | 11.66 Million EUR | 70.88% |
| 2022 Q4 | 12.67 Million EUR | 52.98% |
| 2022 FY | 28.81 Million EUR | 25.78% |
| 2022 Q1 | 6.82 Million EUR | -35.45% |
| 2022 Q3 | 8.28 Million EUR | -28.97% |
| 2021 Q1 | 5.75 Million EUR | -27.21% |
| 2021 FY | 22.9 Million EUR | 23.61% |
| 2021 Q4 | 10.57 Million EUR | 84.56% |
| 2021 Q3 | 5.72 Million EUR | -41.05% |
| 2021 Q2 | 9.71 Million EUR | 68.96% |
| 2020 Q4 | 7.9 Million EUR | 70.86% |
| 2020 Q3 | 4.62 Million EUR | -43.26% |
| 2020 Q1 | 4.69 Million EUR | -32.89% |
| 2020 Q2 | 8.14 Million EUR | 73.45% |
| 2020 FY | 18.53 Million EUR | 25.76% |
| 2019 FY | 14.73 Million EUR | 5.65% |
| 2019 Q4 | 7 Million EUR | 82.36% |
| 2019 Q3 | 3.83 Million EUR | -35.77% |
| 2019 Q2 | 5.97 Million EUR | 66.84% |
| 2019 Q1 | 3.58 Million EUR | -34.28% |
| 2018 Q4 | 5.45 Million EUR | 43.8% |
| 2018 Q2 | 2.55 Million EUR | 0.0% |
| 2018 FY | 13.94 Million EUR | 63.9% |
| 2018 Q1 | 2.55 Million EUR | 40.25% |
| 2018 Q3 | 3.79 Million EUR | 48.4% |
| 2017 Q4 | 1.82 Million EUR | -16.55% |
| 2017 Q3 | 2.18 Million EUR | 0.0% |
| 2017 FY | 8.5 Million EUR | -43.69% |
| 2016 FY | 15.11 Million EUR | 19.18% |
| 2015 FY | 12.68 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Affluent Medical SA | 11.86 Million EUR | -153.156% |
| Bluelinea Société Anonyme | 11.43 Thousand EUR | -262506.181% |
| Carmat SA | 21.54 Million EUR | -39.407% |
| Diagnostic Medical Systems S.A. | 18.1 Million EUR | -65.891% |
| Euromedis Groupe | 17.6 Million EUR | -70.59% |
| Eurobio Scientific Société anonyme | 47.34 Million EUR | 36.555% |
| Ikonisys S.A. | 2.44 Million EUR | -1126.325% |
| Implanet S.A. | 9.29 Million EUR | -223.318% |
| Median Technologies SA | 46.34 Million EUR | 35.179% |
| SpineGuard SA | 7.35 Million EUR | -308.415% |
| Theraclion SA | -1.08 Million EUR | 2880.446% |
| Euroapi S.A. | 398.9 Million EUR | 92.469% |
| Guerbet SA | 550.79 Million EUR | 94.546% |
| Ion Beam Applications SA | 128.02 Million EUR | 76.536% |
| Koninklijke Philips N.V. | 5.84 Billion EUR | 99.486% |